Factual headline with ticker: Apimeds Pharmaceuticals US, Inc. (APUS) Two Directors Resign
Apimeds Pharmaceuticals US, Inc. (APUS) announced two directors resigned from its board on December 5, 2025, according to an SEC 8-K filing.
$APUS
Apimeds Pharmaceuticals US (APUS) Announces Merger and $120.9M Financing in SEC Filing
Apimeds Pharmaceuticals US (APUS) filed an 8-K disclosing a merger agreement and a $120.9 million securities purchase amendment.